Journal of Pathology and Translational Medicine

Original Article

The Usefulness of Immunocytochemistry of CD56 in Determining Malignancy from Indeterminate Thyroid Fine-Needle Aspiration Cytology: Hyunseo Cha, Ju Yeon Pyo, Soon Won Hong; J Pathol Transl Med. 2018;52(6):404-410. Published online October 15, 2018; DOI: https://doi.org/10.4132/jptm.2018.09.20

6,764 View
156 Download
5 Web of Science
4 Crossref

Background
Fine-needle aspiration cytology serves as a safe, economical tool in evaluating thyroid nodules. However, about 30% of the samples are categorized as indeterminate. Hence, many immunocytochemistry markers have been studied, but there has not been a single outstanding marker. We studied the efficacy of CD56 with human bone marrow endothelial cell marker-1 (HBME-1) in diagnosis in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) category III.
Methods
We reviewed ThinPrep liquid-based cytology (LBC) samples with Papanicolaou stain from July 1 to December 31, 2016 (2,195 cases) and selected TBSRTC category III cases (n = 363). Twenty-six cases were histologically confirmed as benign (six cases, 23%) or malignant (20 cases, 77%); we stained 26 LBC slides with HBME-1 and CD56 through the cell transfer method. For evaluation of reactivity of immunocytochemistry, we chose atypical follicular cell clusters.
Results
CD56 was not reactive in 18 of 20 cases (90%) of malignant nodules and showed cytoplasmic positivity in five of six cases (83%) of benign nodules. CD56 showed high sensitivity (90.0%) and relatively low specificity (83.3%) in detecting malignancy (p = .004). HBME-1 was reactive in 17 of 20 cases (85%) of malignant nodules and was not reactive in five of six cases (83%) of benign nodules. HBME-1 showed slightly lower sensitivity (85.0%) than CD56. The specificity in detecting malignancy by HBME-1 was similar to that of CD56 (83.3%, p = .008). CD56 and HBME-1 tests combined showed lower sensitivity (75.0% vs 90%) and higher specificity (93.8% vs 83.3%) in detecting malignancy compared to using CD56 alone.
Conclusions
Using CD56 alone showed relatively low specificity despite high sensitivity for detecting malignancy. Combining CD56 with HBME-1 could increase the specificity. Thus, we suggest that CD56 could be a useful preoperative marker for differential diagnosis of TBSRTC category III samples.

Citations

Citations to this article as recorded by

Preoperative evaluation of thyroid nodules – Diagnosis and management strategies
Tapoi Dana Antonia, Lambrescu Ioana Maria, Gheorghisan-Galateanu Ancuta-Augustina
Pathology - Research and Practice.2023; 246: 154516. CrossRef
Immunocytochemistry in thyroid cytology and its multiple roles: a systematic review
Federica Policardo, Pietro Tralongo, Angela Feraco, Federica Vegni, Angela Carlino, Alfredo Pontecorvi, Celestino Pio Lombardi, Marco Raffaelli, Francesco Pierconti, Luigi Maria Larocca, Esther Diana Rossi
Diagnostic Histopathology.2023; 29(8): 386. CrossRef
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology
Isabella Piga, Vincenzo L’Imperio, Giulia Capitoli, Vanna Denti, Andrew Smith, Fulvio Magni, Fabio Pagni
Expert Review of Proteomics.2023; 20(12): 419. CrossRef
CD56 Expression in Papillary Thyroid Carcinoma Is Highly Dependent on the Histologic Subtype: A Potential Diagnostic Pitfall
Uiju Cho, Yourha Kim, Sora Jeon, Chan Kwon Jung
Applied Immunohistochemistry & Molecular Morphology.2022; 30(5): 389. CrossRef

Case Study

A Rare Case of Aggressive Melanotic Schwannoma Occurred in Spinal Nerve of a 59-Year-Old Male: Sung-eun Choi, Yoon Jin Cha, Jisup Kim, Hyunseo Cha, Jayeong Seo, Sung-Uk Kuh, Sung-Jun Kim, Se Hoon Kim; J Pathol Transl Med. 2017;51(5):505-508. Published online April 4, 2017; DOI: https://doi.org/10.4132/jptm.2017.01.04

11,827 View
210 Download
18 Web of Science
15 Crossref

Abstract PDF

Melanotic schwannoma (MS) is a rare variant of nerve sheath neoplasm that shows ultrastructural and immunophenotypical features of Schwann cells but also has cytoplasmic melanosomes and is reactive for melanocytic markers as well. Unlike conventional schwannoma, which is totally benign, MS has an unpredictable prognosis and is thought to have low-malignant potential. Herein, we present a rare case of recurrent MS in lumbar spine of a 59-year-old male.

Citations

Citations to this article as recorded by

Case Report: Cutaneous melanocytic schwannoma with concomitant melanocytoma in a canine
Olwam H. Monakali, Nicolize O'Dell, Louise van der Weyden
Wellcome Open Research.2024; 8: 364. CrossRef
A Rare Case of Melanotic Schwannoma Occurred Intraosseous of Sacrum: A Literature Review
Xiaobo Yan, Keyi Wang, Nong Lin, Xin Huang, YanBiao Fu, Zhaoming Ye
Orthopaedic Surgery.2023; 15(2): 655. CrossRef
Sporadic spinal psammomatous malignant melanotic nerve sheath tumor: A case report and literature review
Giulio Bonomo, Alessandro Gans, Elio Mazzapicchi, Emanuele Rubiu, Paolo Alimonti, Marica Eoli, Rosina Paterra, Bianca Pollo, Guglielmo Iess, Francesco Restelli, Jacopo Falco, Francesco Acerbi, Marco Paolo Schiariti, Paolo Ferroli, Morgan Broggi
Frontiers in Oncology.2023;[Epub] CrossRef
Case Report: Cutaneous melanocytic schwannoma with concomitant melanocytoma in a canine
Olwam H. Monakali, Nicolize O'Dell, Louise van der Weyden
Wellcome Open Research.2023; 8: 364. CrossRef
Fine‐needle aspiration cytology of melanotic schwannoma in the submandibular gland
Yu‐Hua Huang, Ying‐Chou Lu, Hsuan‐Ying Huang, Chien‐Chin Chen
Diagnostic Cytopathology.2021; 49(1): 142. CrossRef
Checkpoint inhibitors and radiotherapy in refractory malignant melanocytic schwannoma with Carney complex: first evidence of efficacy
Jyoti Bajpai, Akhil Kapoor, Rakesh Jalali, Mrinal M Gounder
BMJ Case Reports.2021; 14(5): e240296. CrossRef
18F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root
Xun-Ze Shen, Wei Wang, Zhou-Ye Luo
Medicine.2021; 100(8): e24803. CrossRef
Hemorrhagic spinal melanotic schwannoma presenting as acute chest pain: A case report and literature review
Dallas J. Soyland, Dylan R. Goehner, Kayla M. Hoerschgen, Troy D. Gust, Shawn M. Vuong
Surgical Neurology International.2021; 12: 164. CrossRef
Retroperitoneal Recurrence of Melanotic Schwannoma on 18F-FDG PET/CT
Xiangliu OuYang, Lichun Zheng, Xiaoming Zhang
Clinical Nuclear Medicine.2021; 46(12): 991. CrossRef
Schwannoma originating from the common iliac artery: a case report
Seung-Myoung Son, Chang Gok Woo
Journal of International Medical Research.2020; 48(2): 030006051984979. CrossRef
Intraosseous Melanotic Schwannoma in the Sacrum Mimicking Primary Bone Tumor
Yoshitaka Nagashima, Yusuke Nishimura, Kaoru Eguchi, Takayuki Awaya, Satoshi Yoshikawa, Shoichi Haimoto, Toshihiko Wakabayashi, Masahito Hara
NMC Case Report Journal.2020; 7(3): 107. CrossRef
Extramedullary melanotic schwannoma recurrence in the cervical vertebral arch: a case report and review of the literature
Zongbin Hou, Teng Shi, Guangrun Li, Lin Tian, Xinna Li, Xiaoyang Liu
Journal of International Medical Research.2020; 48(8): 030006052094791. CrossRef
Extramedullary malignant melanotic schwannoma of the spine: Case report and an up to date systematic review of the literature
Georgios Solomou, Adikarige Haritha Dulanka Silva, Adrianna Wong, Ute Pohl, Nikolaos Tzerakis
Annals of Medicine and Surgery.2020; 59: 217. CrossRef
Melanotic Schwannoma of the Vagina: A Report of a Very Rare Tumor and Review of the Literature
Kofi Effah, Stefan Seidl, Edith Gorges, Patrick Kafui Akakpo
Case Reports in Obstetrics and Gynecology.2019; 2019: 1. CrossRef
Melanotic Schwannomas Are Rarely Seen Pigmented Tumors with Unpredictable Prognosis and Challenging Diagnosis
Elif Keskin, Sumeyye Ekmekci, Ozgur Oztekin, Gulden Diniz
Case Reports in Pathology.2017; 2017: 1. CrossRef

First
Prev
Page of 1
Next
Last

Search